Argine vasopressin (AVP) has a variety of physiological actions through its binding to specific receptors, V 1a , V 1b , and V 2 , e.g., vasoconstriction, stimulation of platelet aggregation, hepatocyte glycogenolysis, corticotropin release stimulation and antidiuresis.
There have been several studies on the relation between AVP and intraocular pressure (IOP). Palm D. E. et al. reported that the intracerebroventricular injection and intravenous infusion of AVP caused a decrease in IOP accompanied by the elevation of blood pressure (BP) probably due to its vasoconstrictor effects. 9) Wallace I. et al. reported that the direct infusion of AVP into the anterior chamber of eye increased IOP in anesthetized rats, and that the intravenous administration of desmopressin, a selective vasopressin V 2 receptor agonist, increased IOP without significant alteration in BP and aqueous humor formation in rabbit. 10) Recently, it was reported that SR121463, a selective non-peptide vasopressin V 2 receptor antagonist, significantly decreased IOP in a-chymotripsin induced ocular hypertensive rabbit, 11) and that the intravenous injection and direct infusion into the anterior chamber of AVP decreased IOP accompanied with a decrease in pupil diameter, while the intracerebroventricular injection of AVP increased IOP.
12) The studies which have been reported to date show that a definite idea on the relationship between AVP, AVP receptors and IOP has not been established.
In the present paper, to elucidate the relation between AVP and IOP, we studied the distribution of vasopressin receptors in cynomolgus monkey eye and the effect of several vasopressin antagonists such as VP-343, YM087, OPC-31260, OPC-21268, and SR121463, whose chemical structures are shown in Fig. 1 , on normal IOP in rabbit.
MATERIALS AND METHODS
Materials VP-343, OPC-21268, YM087, OPC-31260, and SR121463 were synthesized at WAKAMOTO Pharmaceutical Co., Ltd. Benoxil ® (0.4%) was purchased from Santen Co., Ltd.
Animals Healthy male Japanese albino rabbits weighing about 2.0-3.0 kg (Kitayama Labes, Japan) and male cynomolgus monkey (LABSIND C.V.) were used. Both animals were housed in a communal cage and maintained on a 12 h light/dark cycle. Rabbits and monkey were given 100 and 500 g of food/day, respectively and water available ad libitum.
IOP Measurements in Normotensive Rabbit Rabbits were divided into two groups in each experiment. Male Japanese albino rabbits which had been accustomed to the IOP measurement were used. IOP were measured with Pneumatic Applanation Tonograph (Alcon) calibrated previously. One drop of Benoxil ® (0.4%) was instilled as a local anesthetic immediately prior to each IOP measurement. After the measurement of the initial value of IOP, VP-343, OPC-21268, SR121463 and YM087 (dissolved in N,N-dimethylformamide (DMF)) and OPC-31260 (dissolved in saline) were administered intravenously. For VP-343 and YM087, the dose was 3 mg/kg, and IOP was measured at 0.5, 1, 2, 3, 4, 5, and 6 h. For SR121463, the dose was 3 mg/kg, and IOP was measured at 1, 2, 3, and 4 h. For OPC-21268 and OPC-31260, the dose was 10 mg/kg, and IOP was measured at 0.5, 1, 2, 3, and 4 h. The average values of IOP measured 3 times serially and repeatedly were adopted as the data for each point. Changes in IOP (DIOP) were calculated by subtracting the initial IOP from each IOP. The statistical analysis was performed using the student's t test and Aspin-Welth's t-test.
IOP Measurements in Normotensive Rabbit Rabbits were divided into two groups. Rabbit left eye was photographed with reference ruler by digital camera (Fine Pix 2700, Fuji) under constant illumination (about 500 lux). Photographs were printed out and pupil diameters were measured by digimatic caliper (matunami). After the measurement of the initial pupil diameter, VP-343 (dissolved in DMF) was administered intravenously at the dose of 3 mg/kg. Left eye in each rabbit was photographed at 0.5, 1, 2, 3, and 4 h after administration. Each pupil diameter was measured as described above. Changes in pupil diameter (DPD) were calculated by subtracting the initial pupil diameter from each pupil The aim of the present paper is to study the relation between vasopressin antagonism and the regulation of intraocular pressure ( diameter. The statistical analysis was performed using the student's t-test and Aspin-Welth's t-test.
Vasopressin Receptor Mapping Study in Cynomolgus Monkey Eye A male cynomolgus monkey (4 or 5 years old) was used. The monkey, under anesthesia, was sacrificed by bleeding. Eye balls were rapidly removed, soaked in OCT compound (Tissue-Tek, Sakura Finetechnical Co., Ltd.) and then frozen in liquid nitrogen at Ϫ196°C. Forty sheets of sliced samples were obtained by cutting the eye balls equatorially from cornea to optic discs in 10 mm width by cryostat (CM3000, Leica microsystems). The slices were mounted on poly-L-lysine coated glass slides (matsunami). Slide mounted sections (sections) were dried with cold air and were stored at Ϫ80°C until use. ]-vasopressin. After incubation, the sections were soaked two times in the same cold buffer for 2 min, washed with ice cold water, dried with cold air, stuck on an imaging plate, and then exposed for 72 h. The exposed imaging plate was scanned and the emitted stored energy quantified as photo-stimulated luminescence (PSL) with a Bio-Image Analyser (BAS 2500 Fuji) under specific reading conditions: gradiation 256; resolution 100; sensitivity 10000; Latitude 4. Photographs of the autoradiographic images were obtained using a pictrography (Fuji).
The red and yellow region in the photographs indicated the high density binding sites and especially, the red region indicated the highest density binding site for the 
RESULTS AND DISCUSSION
The IOP values before and after administration of each compound are shown in Fig. 4 . SR121463 had no effect on IOP. However, the DIOP of YM087, VP-343, OPC-21268 , and OPC-31260 groups were 1.8-5.9, Ϫ0.2-3.4, 0.5-3.2, and Ϫ0.4-1.4 mmHg lower than each corresponding control value, respectively. The intravenous injection of YM087, OPC-21268 and VP-343 clearly decreased normal IOP in rabbit.
Gondim E. L. et al. reported that the intravenous, anterior chamber or vitreous chamber injection of AVP (1-100 mM) decreased IOP and pupil diameter dose-dependently.
12) It was reported that pilocarpine decreased IOP as a result of the reduction of PD.
13) Therefore, we investigated the influence of VP-343 on PD in rabbit. Intravenous administration of VP-343 at a dose of 3 mg/kg had no influence on PD in rabbit. The mechanism for the reduction of IOP by a vasopressin antagonist is unknown. However, these findings suggested that a vasopressin antagonist should decrease IOP without any influence on PD.
To investigate the relation between the reduction of IOP and the distribution of the vasopressin receptor in eye, a vasopressin V 1 and V 2 receptor mapping study was performed. The results of the vasopressin V 1 and V 2 receptor mapping study in cynomolgus monkey are shown in Figs. 4 and 5. No sign of the existence of a V 2 receptor was observed in the V 2 receptor mapping study.
In contrast, the V 1 receptor mapping study showed the existence of vasopressin V 1 receptors in the region of iris in normal cynomolgus monkey eye. On the basis of the previous binding studies in rat, [14] [15] [16] the rank order of binding affinities for vasopressin V 1a receptor is as follows: YM087Ͼ ϾOPC-21268мVP-343мOPC-31260мSR121463. These findings lead to the idea that a vasopressin antagonist might play some role in regulating normal IOP via binding to the vasopressin V 1 receptor. However, there is no evidence that vasopressin receptor distribution in rabbit eye is identical with that in monkey eye. Furthermore, the rank order of binding affinities for the vasopressin V 1a receptor in rabbit among these vasopressin antagonists is unknown. Therefore, for further understanding of the relation between the vasopressin V 1a receptor and IOP, further studies will be required, including a rabbit vasopressin receptor binding study of these compounds, the distribution of vasopressin receptor subtypes in ocular hypertensive and normal rabbit eyes and the influence of vasopressin antagonists in IOP in monkey.
In conclusion, from the studies on normal IOP and PD in rabbits and vasopressin receptor mapping study in monkey, we suggest that the mechanism of vasopressin antagonism for regulation of rabbit normal IOP is different from that of vasopressin and that vasopressin V 1 receptors are present in monkey iris. 
